National Cancer Institute
Annual Progress Report 2010
by John E. Niederhuber, MD, outgoing director, National Cancer Institute
As the 13th director of the National Cancer Institute, virtually every day brought me a fresh reminder of the privilege and excitement that stem from being part of a proud organization with an extraordinary history of groundbreaking biomedical research.The honor of serving this federal agency – and the millions of cancer patients and survivors who count on its vital efforts – only grew stronger as I prepared to step aside from its directorship.
New Developments in Cancer ResearchAdvances in cancer treatment presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
Recognizing and Treating Carcinoid Tumors
by Daniel Joo and Nancy LindholmCarcinoid cancer is the term used to refer to tumors that originate in the nerve cells that produce hormones, also known as the neuroendocrine system. About half of these rare tumors begin in the digestive system – the stomach, small intestine, appendix, colon, or rectum. They can also appear in the lungs or, less frequently, in other organs, such as the pancreas or ovaries.
Higher Risk for Heart Disease and Diabetes Associated with Androgen Deprivation Therapy
Men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists (GnRH), have an increased risk of diabetes and cardiovascular disease, according to a new study published in the Journal of the National Cancer Institute.
Keeping Your Own Medical Records
by Jody Pelusi, PhD, FNP, AOCNP
It’s always a good idea for you to keep your own complete, updated medical records so you can play an active, informed role in your care. This is especially true after a cancer diagnosis. Though this may seem an overwhelming task at first, what you need may be simpler than you think.
Living with Diabetes and Cancer
by Veronica Brady, FNP-BC, BC-ADM, CDE
Glucometer, check. Test strips, check. Lancets, check. Snack, check. Bottled water, check. Diabetes medications, check. Cell phone, check. These items are part of the daily checklist of every person with diabetes leaving home for any length of time. Now imagine this same individual going to a cancer treatment center for a full day of testing, chemotherapy, office visits, etc. Sound familiar?
Maximizing Cancer Pain Management
by Betty Ferrell, RN, PhD, MA, FAAN, FPCN, and Tami Borneman, RN, MSN, CNS, FPCN
Madeline Brown is a 42-year-old woman diagnosed with stage II ovarian cancer. She has responded well to surgery and chemotherapy and in many ways has resumed her life. However, Mrs. Brown has been experiencing pain, pelvic and vaginal discomfort, and moderate to severe peripheral neuropathy. The pain is causing significant disruption in her life. As the months progress and her pain continues, Mrs. Brown becomes anxious and depressed, and her family becomes increasingly concerned.
Drug Treatment for Cutaneous T-cell Lymphoma Approved
The U.S. Food and Drug Administration has approved Gloucester Pharmaceuticals’ Istodax® (romidepsin), an injectable medication, for treatment of people with a rare form of cancer known as cutaneous T-cell lymphoma.